🔎 Trials Near Me

Akèy › Obèsite › Michigan › Farmington Hills

Etid klinik pou Obèsite nan Farmington Hills, MI

12 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Farmington Hills (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Headlands Research - Detroit, Southfield · 8 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07684235

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Ap rekriteFaz 2
  • Profound Research, Farmington Hills
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07837973

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Great Lakes Research Institute, Southfield · 8 mi lwen
  • Revive Research Institute, Inc., Southfield · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Headlands Research - Detroit, Southfield · 8 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Ap rekriteFaz 3
  • Revive Research Institute, Inc., Southfield · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Farmington Hills
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Southfield · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Revival Research Institute, Southfield · 8 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Headlands Research - Detroit, Southfield · 8 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Farmington Hills
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Farmington Hills
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Henry Ford Health System, Southfield · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Etid Obèsite nan lòt vil

Lòt etid nan Farmington Hills

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.